TriSalus Life Sciences Inc (TLSI): Next-Year EPS Estimate 49.07%
As of 2026-06-11, TriSalus Life Sciences Inc (TLSI) has a next-year EPS growth estimate of 49.07%.
On 2026-05-14, analyst consensus for TLSI's next-year EPS growth shifted from 49.69% to 49.07% — a negative change of 0.62 percentage points. The revised estimate has been sustained across 21 subsequent trading sessions. Current-year growth is projected at 82.50%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 49.07%
- EPS growth this year
- 82.50%
- EPS next quarter (est)
- -$0.15
- Last price
- $3.64
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 49.07% | 82.50% | -$0.15 | $3.64 |
| 2026-06-10 | 49.07% | 82.50% | -$0.15 | $3.55 |
| 2026-06-09 | 49.07% | 82.50% | -$0.15 | $3.34 |
| 2026-06-08 | 49.07% | 82.50% | -$0.15 | $3.21 |
| 2026-06-07 | 49.07% | 82.50% | -$0.15 | $3.17 |
| 2026-06-04 | 49.07% | 82.50% | -$0.15 | $3.30 |
| 2026-06-03 | 49.07% | 82.50% | -$0.15 | $3.18 |
| 2026-06-02 | 49.07% | 82.50% | -$0.15 | $3.34 |
| 2026-06-01 | 49.07% | 82.50% | -$0.15 | $3.67 |
| 2026-05-31 | 49.07% | 82.50% | -$0.15 | $3.41 |
| 2026-05-28 | 49.07% | 82.50% | -$0.15 | $3.27 |
| 2026-05-27 | 49.07% | 82.50% | -$0.15 | $3.19 |
| 2026-05-26 | 49.07% | 82.50% | -$0.15 | $3.22 |
| 2026-05-25 | 49.07% | 82.50% | -$0.15 | $3.26 |
| 2026-05-24 | 49.07% | 82.50% | -$0.15 | $3.26 |
| 2026-05-21 | 49.07% | 82.50% | -$0.15 | $3.45 |
| 2026-05-20 | 49.07% | 82.50% | -$0.15 | $3.24 |
| 2026-05-19 | 49.07% | 82.50% | -$0.15 | $3.15 |
| 2026-05-18 | 49.07% | 82.50% | -$0.15 | $3.03 |
| 2026-05-17 | 49.07% | 82.50% | -$0.15 | $2.68 |
| 2026-05-14 | 49.07% | 82.50% | -$0.15 | $2.52 |
| 2026-05-13 | 49.69% | 82.28% | -$0.13 | $2.81 |
| 2026-05-12 | 67.02% | 79.57% | -$0.16 | $4.56 |
| 2026-05-11 | 67.02% | 79.57% | -$0.16 | $4.54 |
| 2026-05-10 | 67.02% | 79.57% | -$0.16 | $4.43 |
| 2026-05-07 | 67.02% | 79.57% | -$0.16 | $4.46 |
| 2026-05-06 | 67.02% | 79.57% | -$0.16 | $4.55 |
| 2026-05-05 | 67.02% | 79.57% | -$0.16 | $4.61 |
| 2026-05-04 | 67.02% | 79.57% | -$0.16 | $4.45 |
| 2026-05-03 | 67.02% | 79.57% | -$0.16 | $4.39 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is TriSalus Life Sciences Inc's next-year EPS growth estimate?▾
As of 2026-06-11, TriSalus Life Sciences Inc (TLSI) has a next-year EPS growth estimate of 49.07%, based on analyst consensus.
When was the latest EPS estimate revision for TLSI?▾
The most recent revision occurred on 2026-05-14, when analysts adjusted the next-year EPS growth estimate from 49.69% to 49.07%.
What sector and industry does TriSalus Life Sciences Inc belong to?▾
TriSalus Life Sciences Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TLSI appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. TriSalus Life Sciences Inc (TLSI) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports